Aligos Therapeutics, Inc. (ALGS) Reports Q2 Loss, Misses Revenue Estimates

Aligos Therapeutics, Inc. (ALGS) came out with a quarterly loss of $1.53 per share versus the Zacks Consensus Estimate of a loss of $2.35. This compares to earnings of $0.75 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +34.89%. A quarter ago, it was expected that this company would post a loss of $2.8 per share when it actually produced a loss of $2.11, delivering a surprise of +24.64%.Over the last four quarters, the compa ...